Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

Marimed (MRMD) Short-Term Debt repayments (2016 - 2021)

Marimed (MRMD) has disclosed Short-Term Debt repayments for 4 consecutive years, with -$132000.0 as the latest value for Q1 2021.

  • Quarterly Short-Term Debt repayments changed N/A to -$132000.0 in Q1 2021 from the year-ago period, while the trailing twelve-month figure was $1.0 million through Mar 2021, changed N/A year-over-year, with the annual reading at -$1.2 million for FY2021, 290.03% down from the prior year.
  • Short-Term Debt repayments for Q1 2021 was -$132000.0 at Marimed, down from $1.1 million in the prior quarter.
  • The five-year high for Short-Term Debt repayments was $1.1 million in Q4 2019, with the low at -$132000.0 in Q1 2021.
  • Average Short-Term Debt repayments over 3 years is $206463.0, with a median of -$1040.0 recorded in 2019.
  • Peak annual rise in Short-Term Debt repayments hit 7614.88% in 2019, while the deepest fall reached 7614.88% in 2019.
  • Over 3 years, Short-Term Debt repayments stood at -$14087.0 in 2018, then surged by 7614.88% to $1.1 million in 2019, then plummeted by 112.47% to -$132000.0 in 2021.
  • According to Business Quant data, Short-Term Debt repayments over the past three periods came in at -$132000.0, $1.1 million, and $120821.0 for Q1 2021, Q4 2019, and Q2 2019 respectively.